LFTSF - LifeTech Scientific Corporation
NYSE * Healthcare * Medical Devices
$0.23
+$0.00 (+0.00%)
About LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company's products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.
LFTSF Key Statistics
Market Cap
$1.03B
P/E Ratio
23.35
P/B Ratio
2.32
EPS
$0.01
Revenue Growth
+0.1%
Profit Margin
0.1%
Employees
1,276
How LFTSF Compares to Peers
P/E Rank
#1
of 6
Margin Rank
#6
of 6
Growth Rank
#6
of 6
Size Rank
#6
of 6
LifeTech Scientific Corporation Company Information
- Headquarters
- LifeTech Scientific Building, Shenzhen, China, 518063, undefined
- Website
- www.lifetechmed.com
- Sector
- Healthcare
- Industry
- Medical Devices